Search General Info
Search Education
Search Partnering Companies


Missoula, MT, United States of America
DermaXon is drug discovery and development company providing first in-class drug candidates. DermaXon targets the brain-skin-immune system connection to develop novel therapeutic strategies to treat life-threatening diseases and disorders such as pain, pruritus and cutaneous lupus. The company core technology is based on the design and development of small molecules and proteolysis targeting chimera (PROTAC) modulating understudied targets. DermaXon uses medicinal chemistry, molecular biology, artificial intelligence and machine learning, and RNA sequencing to characterize and identify synergies and overlaps between biological signaling pathways modulated by these molecules and triggering the initiation of diseases and disorders.